{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Febrile Neutropenia in the Chemotherapy Patient

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify features of febrile neutropenia.
  2. Summarize steps in the initial management of a patient with febrile neutropenia.
  3. Assess the level of risk for a patient experiencing febrile neutropenia.
  4. Identify interventions to help prevent febrile neutropenia in a patient receiving chemotherapy.

Learning Outcomes

Seventy-five percent of participants will demonstrate competency in clinical reasoning regarding the identification and management of febrile neutropenia in patients undergoing chemotherapy by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $21.95

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: AJN0523
Published: May 2023
Expires: 3/6/2026
Collections: CESaver
Required Passing Score: 8/10 (80%)
Authors: Anne Marie Foley, MS, RN, ACNS-BC, CCRN-K; Megan Hoffman, MSN, RN, AOCNS, AGCNS-BC, EBP (CH)